<bill session="116" type="s" number="1532" updated="2019-10-30T16:41:31Z">
  <state datetime="2019-05-16">REFERRED</state>
  <status>
    <introduced datetime="2019-05-16"/>
  </status>
  <introduced datetime="2019-05-16"/>
  <titles>
    <title type="official" as="introduced">A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.</title>
    <title type="short" as="introduced">Pharmacy Benefit Manager Accountability Study Act of 2019</title>
    <title type="short" as="introduced">Pharmacy Benefit Manager Accountability Study Act of 2019</title>
    <title type="display">Pharmacy Benefit Manager Accountability Study Act of 2019</title>
  </titles>
  <sponsor bioguide_id="B001243"/>
  <cosponsors>
    <cosponsor bioguide_id="B001310" joined="2019-05-16"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-16">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-05-16" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
